Current status of pediatric intestinal failure, rehabilitation, and transplantation: Summary of a colloquium

Transplantation

Volumn 92, Issue 11, 2011, Pages 1173-1180

  Mazariegos, George V ^a,b   Superina, Riccardo ^c,d,e   Rudolph, Jeffrey ^a   Cohran, Valeria ^a,c,e   Burns, R Cartland ^f   Bond, Geoffrey J ^a,b,f   Jaffe, Ronald ^a   Sindhi, Rakesh ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Hillman Center for Pediatric Transplantation   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d Kidney and Liver Transplant Programs   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Intestine rehabilitation; Pediatric intestinal failure; Transplantation

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BASILIXIMAB; CD40 LIGAND; CLONIDINE; COMPLEMENT COMPONENT C4D; DOCOSAHEXAENOIC ACID; ERYTHROMYCIN; HLA ANTIGEN; ICOSAPENTAENOIC ACID; LINACLOTIDE; LINOLEIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITAZOXANIDE; OCTREOTIDE; OKT 3; OMEGA 3 FATTY ACID; PREBIOTIC AGENT; PREDNISONE; PRUCALOPRIDE; RAPAMYCIN; RIFAXIMIN; SHORT CHAIN FATTY ACID; STEROID; TACROLIMUS; TEDUGLUTIDE; THYMOCYTE ANTIBODY;

ARTICLE; CHILD CARE; CONVALESCENCE; DONOR SELECTION; ENTERIC FEEDING; ENTEROPATHY; ESSENTIAL FATTY ACID DEFICIENCY; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HOSPITAL ADMISSION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; INTESTINAL DYSMOTILITY; INTESTINE FAILURE; INTESTINE LENGTHENING; INTESTINE REHABILITATION; INTESTINE RESECTION; INTESTINE SURGERY; INTESTINE TRANSPLANTATION; LAPAROTOMY; ORGAN DONOR; PATIENT MONITORING; PATIENT REFERRAL; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; REHABILITATION; RISK BENEFIT ANALYSIS; SECOND LOOK SURGERY; SMALL INTESTINE BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; SYMPOSIUM; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHICAGO; CHILD; CHILD, PRESCHOOL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; INTESTINAL DISEASES; INTESTINES; PARENTERAL NUTRITION; TREATMENT OUTCOME;

EID: 81855201733     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318234c325     Document Type: Article

References (39)

1. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birth weight infants. Am J Obstet Gynecol 2007; 196: 147 e1.
2. Nayyar N, Mazariegos G, Ranganathan S, et al. Pediatric small bowel transplantation. Semin Pediatr Surg 2010; 19: 68.
3. Sisk PM, Lovelady CA, Dillard RG, et al. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007; 27: 428.
4. Tappenden KA, Albin DM, Bartholome AL, et al. Glucagon-like peptide-2 and short-chain fatty acids:Anew twist to an old story. J Nutr 2003; 133: 3717.
5. Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. J Parenter Enteral Nutr 2000; 24: 345.
6. Cober MP, Teitelbaum DH. Prevention of parenteral nutrition-associated liver disease: Lipid minimization. Curr Opin Organ Transplant 2010; 15: 330.
7. Puder M, Valim C, Meisel J, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009; 250: 395.
8. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121: e678.
9. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: A single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2010; 34: 485.
10. Onder AM, Chandar J, Billings AA, et al. Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia. Clin J Am Soc Nephrol 2008; 3: 1048.
11. Ching YA, Modi BP, Jaksic T, et al. High diagnostic yield of gastrointestinal endoscopy in children with intestinal failure. J Pediatr Surg 2008; 43: 906.
12. Cole CR, Frem JC, Schmotzer B, et al. The rate of bloodstream infection is high in infants with short bowel syndrome: Relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. J Pediatr 2010; 156: 941.
13. Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed 2007; 92: F193.
14. Schulzke SM, Deshpande GC, Patole SK. Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: A systematic review of observational studies. Arch Pediatr Adolesc Med 2007; 161: 583.
15. Bianchi A. Intestinal lengthening: An experimental and clinical review. J R Soc Med 1984; 77(suppl 3): 35.
16. Kim HB, Lee PW, Garza J, et al. Serial transverse enteroplasty for short bowel syndrome: A case report. J Pediatr Surg 2003; 38: 881.
17. Bianchi A. From the cradle to enteral autonomy: The role of autologous gastrointestinal reconstruction. Gastroenterology 2006; 130: S138.
18. Bianchi A. Experience with longitudinal intestinal lengthening and tailoring. Eur J Pediatr Surg 1999; 9: 256.
19. Modi BP, Javid PJ, Jaksic T, et al. First report of the international serial transverse enteroplasty data registry: Indications, efficacy, and complications. J Am Coll Surg 2007; 204: 365.
20. Modi BP, Ching YA, Langer M, et al. Preservation of intestinal motility after the serial transverse enteroplasty procedure in a large animal model of short bowel syndrome. J Pediatr Surg 2009; 44: 229.
21. Sudan D, DiBaise J, Torres C, et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg 2005; 9: 165.
22. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009; 19: 348.
23. Mazariegos GV, Steffick DE, Horslen S, et al. Intestine transplantation in the United States, 1999-2008. Am J Transplant 2010; 10: 1020.
24. Testa G, Holterman M, Abcarian H, et al. Simultaneous or sequential combined living donor-intestine transplantation in children. Transplantation 2008; 85: 713.
25. Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: Implications for intestinal transplantation. Gut 2011; 60: 17.
26. Kaufman SS, Atkinson JB, Bianchi A, et al. Indications for pediatric intestinal transplantation: A position paper of the American Society of Transplantation. Pediatr Transplant 2001; 5: 80.
27. Beath S, Pironi L, Gabe S, et al. Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation 2008; 85: 1378.
28. Botha JF, Grant WJ, Torres C, et al. Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. Liver Transpl 2006; 12: 1062.
29. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 report of the intestine transplant registry: A new era has dawned. Ann Surg 2005; 241: 607.
30. Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: Major advances with new challenges. Ann Surg 2009; 250: 567.
31. Abu-Elmagd KM, Mazariegos G, Costa G, et al. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: Improved outcomes with new outlooks. Transplantation 2009; 88: 926.
32. Fishbein T, Novitskiy G, Mishra L, et al. NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 2008; 57: 323.
33. Ningappa M, Higgs BW, Weeks DE, et al. NOD2 Gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome. Am J Gastroenterol 2011; 106: 157.
34. Sindhi R, AshokKumar C, Mazariegos G, et al. Immune monitoring in small bowel transplantation. Curr Opin Organ Transplant 2010; 15: 349.
35. Ashokkumar C, Gupta A, Sun Q, et al. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation. Surgery 2009; 146: 166.
36. Ashokkumar C, Bentlejewski C, Sun Q, et al. Allospecific CD154+ B cells associate with intestine allograft rejection in children. Transplantation 2010; 90: 1226.
37. Farmer DG, Venick RS, Colangelo J, et al. Pretransplant predictors of survival after intestinal transplantation: Analysis of a single-center experience of more than 100 transplants. Transplantation 2010; 90: 1574.
38. Takemoto SK, Zeevi A, Feng S, et al. National Conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033.
39. Revelo MP, Stehlik JM, Miller D, et al. Antibody testing for cardiac antibody-mediated rejection: Which panel correlates best with cardiovascular death? J Heart Lung Transplant 2011; 30: 144.